近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
(1) Qin Tao, Yuan Zhong-Yu, Peng Rou-Jun, Bai Bing Zeng, Yin-Duo Shi, Yan-Xia Teng, Xiao-Yu Liu, Dong-Geng Wang, Shu-Sen(*). Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China., Archives of Medical Science,2015,11(3):544-550. (2) Yuan Zhong-Yu ,Luo Rong-Zhen, Peng Rou-Jun, Wang Shu-Sen, Xue Cong. High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis.,OncoTargets and herapy,2014,7: 1475-1480. (3) Yuan Zhong-Yu, Dai Ting ,Wang Shu-Sen, Peng Rou-Jun, Li Xing-Hua, Qin, Tao, Song Li-Bing, Wang Xi, Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis. OncoTargets and Therapy,2014,7:1733-1742. (4) Luo Rong-Zhen, Yuan Zhong-Yu, Li Mei, Xi Shao-Yan, Fu Jia, He Jiehua(*), Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer.,OncoTargets and Therapy,2013,6:883-888. (5) Qin Tao, Yuan Zhongyu, Peng Roujun, Bai Bing, Shi Yanxia, Teng Xiaoyu, Liu Donggeng, Wang Shusen(*), HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients.,OncoTargets and Therapy,2013,6:341-347. (6) Dong Min,Wan, Xiang-bo, Yuan Zhong Yu, Wei Li Fan, Xin Juan Wang, Tian-tian Lv, Yan Chun Li, Xing Chen, Zhan-hong Chen, Jie Lin, Qu Wen, Jing-yun Ma, Xiao-kun, Liu Quentin(*), Wu Xiang Yuan(*), Low expression of Beclin 1 and elevated expression of HIF-1alpha refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer.,Medical Oncology,2013,30(1):355-355. (7) Qin T. Yuan ZY, Peng RJ, Zeng YD, Shi YX, Teng XY, Liu DG, Bai B, Wang SS(*), Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: A retrospective analysis,Current Oncology,2013,20(4):196-204. (8) Xue Cong, Peng Roujun, Cao Ye, Wang Shusen, Shi Yanxia, An Xin, Xu Fei, Yuan Zhongyu(*), Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer.,PLos One,2016,11(2):e0148849-e0148849. (9) Qin Tao, Zeng Yin-duo, Qin Ge, Xu Fei, Lu Jia-bin, Fang Wen-feng, Xue Cong, Zhan Jian-hua, Zhang Xin-ke, Zheng Qiu-fan, Peng Rou-jun, Yuan Zhong-yu(*), Zhang Li(*), Wang Shu-sen(*), High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer.,Oncotarget,2015,6(32):33972-33981. (10) Xue Cong, Peng RouJun, Wang ShuSen, Shi YanXia, An, Xin, Xu Fei, Yuan Zhong Yu(*), Operable breast cancer of the inner hemisphere is associated with poor survival.,Journal of Breast Cancer,2015,18(1):36-43. (11) Li Xinghua, Liang Weijiang, Liu Junling, Lin Chuyong, Wu, Shu, Song Libing, Yuan Zhongyu(*), Transducin (ss)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.,Breast Cancer Research,2014,16(5):465-465. (12) Xu Jie, Wu Xing, Zhou Wei-hua, Liu An-wen, Wu Jian-bing, Deng Jin-yun, Yue Cai-feng, Yang Shao-bing, Wang Jing, Yuan Zhong-yu(*), Liu Quentin(*), Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer.,PLos One,2013,8(2):e56919-e56919. (13) He Jie-Hua, Luo Rong-Zhen, Cai Mu-Yan, Li Mei, Lu Jia-Bing, Yuan Zhong-Yu(*), Decreased expression of light chain 3 (LC3) increased the risk of distant metastasis in triple-negative breast cancer.,Medical Oncology,2013,30(1):468-468. (14) Fang Wang, Wenzhuo He, Huijuan Qiu, Xi Wang, Guifang Guo, Xuxian Chen, Yuming Rong, Feifei Zhou, Chenxi Yin, Zhongyu Yuan(*), Liangping Xia(*), Lymph Node Ratio and pN Staging Show Different Superiority As Prognostic Predictors Depending on the Number of Lymph Nodes Dissected in Chinese Patients With Luminal A Breast Cancer,Clinical Breast Cancer,2012,12(6):404-411. (15) Xue Cong, Wang Xi, Peng Roujun, Shi Yanxia, Qin Tao, Liu Donggen, Teng Xiaoyu, Wang Shusen, Zhang Li(*), Yuan Zhongyu(*), Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China.,Cancer Science,2012,103(9):1679-1687. (16) He Jiehua,Peng Roujun,Wang Shusen, Yuan Zhongyu(*), Peng Jiewen, Lin Guinan, Jiang Xiaomei, Qin Tao, Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.,Medical Oncology,2012,29(2):406-410. (17) Wang Shusen, Shi Yanxia, Wang Xi, Liu Donggen, Yuan Zhongyu(*), Peng Roujun, Teng Xiaoyu, Qin Tao, Peng Jiewen, Lin Guinan,Jiang Xiaomei, Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens.,Medical Oncology,2012,29(2):547-553. (18) Liu Donggen, He Jiehua, Wang Shusen, Peng Roujun, Shi Yanxia, Teng Xiaoyu, Qin Tao, Yuan Zhongyu(*), EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray.,Medical Oncology,2012,29(2):401-405. (19) Wang Xi,Wang Shu-Sen,Peng Rou-Jun,Qin Tao,Shi Yan-Xia,Teng Xiao-Yu,Liu Dong-Gen, Chen Wei-Qing, Yuan Zhong-Yu(*), Interaction of coping styles and psychological stress on anxious and depressive symptoms in Chinese breast cancer patients.,Asian Pac J Cancer Prev,2012,13(4):1645-1649. (20) Roujun Peng,Shusen Wang,Yanxia Shi,Donggen Liu,Xiaoyu Teng,Tao Qin,Yixin Zeng(*),Zhongyu Yuan(*),Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: A retrospective matched case–control study,Breast,2011,20(6):568-573.
京公网安备 11010802027423号